Corrigendum to “Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis” [J Hepatol 71 (2019) 543–552]

Thomas Yau; Chiun Hsu; Tae‐You Kim; Su-Pin Choo; Yoon‐Koo Kang; Ming-Mo Hou; Kazushi Numata; Winnie Yeo; Akhil Chopra; Masafumi Ikeda; Ryoko Kuromatsu; Michihisa Moriguchi; Yee Chao; Huanyu Zhao; Jeffrey Anderson; Christine Dela Cruz; Masatoshi Kudo

doi:10.1016/j.jhep.2019.09.013

Related publications

Article2019

Nivolumab in advanced hepatocellular carcinoma: Sorafenib-experienced Asian cohort analysis

Thomas Yau, Chiun Hsu, Tae‐You Kim, Su Pin Choo, Yoon‐Koo Kang, Ming‐Mo Hou, Kazushi Numata, Winnie Yeo, Akhil Chopra, Masafumi Ikeda, Ryoko Kuromatsu, Michihisa Moriguchi, Yee Chao, Huanyu Zhao, Jeffrey Anderson, Christine Dela Cruz, Masatoshi Kudo

Article2023

Nivolumab in sorafenib-naive and sorafenib-experienced patients with advanced hepatocellular carcinoma: 5-year follow-up from CheckMate 040

Yubin Kang, Winnie Yeo, Akhil Chopra, Samira Soleymani, J. Yao, Jaclyn Neely, Marina Tschaika, Theodore H. Welling, Bruno Sangro, Anthony B. El-Khoueiry, Jörg Trojan, Tim Meyer, Thomas Yau, Ignacio Melero, Masatoshi Kudo, Chih‐Hung Hsu, T.-Y. Kim, Su Pin Choo

Article2017

Nivolumab (nivo) in sorafenib (sor)-naive and -experienced pts with advanced hepatocellular carcinoma (HCC): CheckMate 040 study.

Todd S. Crocenzi, Anthony B. El-Khoueiry, Thomas Cheung Yau, Ignacio Melero, Bruno Sangro, Masatoshi Kudo, Chiun Hsu, Jörg Trojan, Tae‐You Kim, Su Pin Choo, Tim Meyer, Yoon‐Koo Kang, Winnie Yeo, Akhil Chopra, Adyb Baakili, Christine Marie Dela Cruz, Lixin Lang, Jaclyn Neely, Theodore H. Welling

Corrigendum2018

Corrigendum to “Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies” [J hepatol 67 (2017) 999–1008]

Jordi Bruix, Ann‐Lii Cheng, Gerold Meinhardt, Keiko Nakajima, Yoriko De Sanctis, Josep M. Llovet

Corrigendum2021

Corrigendum to ‘Molecular characterisation of hepatocellular carcinoma in patients with non-alcoholic steatohepatitis’ [J Hepatol 75 (2021) 865–878]

Roser Pinyol, Sara Torrecilla, Huan Wang, Carla Montironi, Marta Piqué‐Gili, Miguel Torres‐Martín, Wei Qiang Leow, Catherine E. Willoughby, Pierluigi Ramadori, Carmen Andreu-Oller, Patricia Taik, Youngmin A. Lee, Agrin Moeini, Judit Peix, Suzanne Faure‐Dupuy, Tobias Riedl, Svenja Schuehle, Cláudia P. Oliveira, Venâncio Avancini Ferreira Alves, Paolo Boffetta, Anja Lachenmayer, Stephanie Roessler, ,